[Atherosclerosis: secondary drug prevention in view? The animal model provides a solution].
D000818:Animals; D002121:Calcium Channel Blockers / Q000627:therapeutic use*; D002544:Cerebral Infarction / Q000517:prevention & control; D002936:Cinnarizine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D005444:Flunarizine; D002537:Intracranial Arteriosclerosis / Q000517:prevention & control*
D002121:Calcium Channel Blockers; D002936:Cinnarizine; D005444:Flunarizine
Atherosklerose: Medikamentöse Sekundärprophylaxe in Aussicht? Tiermodell liefert Aufschlüsse.